Solution structure of a Plasmodium falciparum AMA-1/MSP 1 chimeric protein vaccine candidate (PfCP-2.9) for malaria

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Peng, Heng ^a   Hu, Yunfei ^b   Zhou, Aiguo ^a   Jin, Changwen ^b   Pan, Weiqing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PFCP 2.9 VACCINE; UNCLASSIFIED DRUG; APICAL MEMBRANE ANTIGEN I, PLASMODIUM; HYBRID PROTEIN; MEMBRANE PROTEIN; PARASITE ANTIGEN; PFCP2.9 VACCINE; PROTOZOAL PROTEIN; RECOMBINANT VACCINE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG STRUCTURE; IMMUNOGENICITY; IN VITRO STUDY; MALARIA FALCIPARUM; NITROGEN NUCLEAR MAGNETIC RESONANCE; NONHUMAN; PICHIA PASTORIS; PLASMODIUM FALCIPARUM; PROTON NUCLEAR MAGNETIC RESONANCE; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE; PICHIA; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALARIA VACCINES; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PICHIA; PLASMODIUM FALCIPARUM; PROTEIN CONFORMATION; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

EID: 77950659057     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-76     Document Type: Article

References (33)

1. Epidemiology of drug-resistant malaria. C Wongsrichanalai AL Pickard WH Wernsdorfer SR Meshnick, Lancet Infect Dis 2002 2 209 218
2. Spread and evolution of Plasmodium falciparum drug resistance. T Mita K Tanabe K Kita, Parasitol Int 2009 58 201 209
3. Insecticide resistance in Anopheles gambiae from south-western Chad, Central Africa. C Kerah-Hinzoumbé M Péka P Nwane I Donan-Gouni J Etang A Samé-Ekobo F Simard, Malar J 2008 7 192
4. Pyrethroid resistance in the major malaria vector Anopheles arabiensis from Gwave, a malaria-endemic area in Zimbabwe. G Munhenga HT Masendu BD Brooke RH Hunt LK Koekemoer, Malar J 2008 7 247
5. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. WA Siddiqui LQ Tam KJ Kramer GS Hui SE Case KM Yamaga SP Chang EB Chan SC Kan, Proc Natl Acad Sci USA 1987 84 3014 3018
6. Antimalarial immunity in Saimiri monkeys: immunization with surface components of asexual blood stages. LH Perrin B Merkli M Loche C Chizzolini J Smart R Richle, J Exp Med 1984 160 441 451
7. Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. RF Anders PE Crewther S Edwards M Margetts ML Matthew B Pollock D Pye, Vaccine 1998 16 240 247
8. Vaccination trials in rhesus monkeys with a minor, invariant Plasmodium knowlesi 66 kD merozoite antigen. JA Deans AM Knight WC Jean AP Waters S Cohen GH Mitchell, Parasite Immunol 1988 10 535 552
9. Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. WE Collins D Pye PE Crewther KL Vandenberg GG Galland AJ Sulzer DJ Kemp SJ Edwards RL Coppel JS Sullivan CL Morris RF Anders, Am J Trop Med Hyg 1994 51 711 719
10. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. MJ Blackman TJ Scott-Finnigan S Shai AA Holder, J Exp Med 1994 180 389 393
11. Band 3 is a host receptor binding merozoite surface protein 1 during the Plasmodium falciparum invasion of erythrocytes. VK Goel X Li H Chen SC Liu AH Chishti SS Oh, Proc Natl Acad Sci USA 2003 100 5164 5169
12. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro. D Nikodem E Davidson, Mol Biochem Parasitol 2000 108 79 91
13. A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites. O Silvie JF Franetich S Charrin MS Mueller A Siau M Bodescot E Rubinstein L Hannoun Y Charoenvit CH Kocken AW Thomas GJ Van Gemert RW Sauerwein MJ Blackman RF Anders G Pluschke D Mazier, J Biol Chem 2004 279 9490 9496
14. Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells. GH Mitchell AW Thomas G Margos AR Dluzewski LH Bannister, Infect Immun 2004 72 154 158
15. Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. K Kato DC Mayer S Singh M Reid LH Miller, Proc Natl Acad Sci USA 2005 102 5552 5557
16. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. RA O'Donnell TF de Koning-Ward RA Burt M Bockarie JC Reeder AF Cowman BS Crabb, J Exp Med 2001 193 1403 1412
17. Pathways and strategies for developing a malaria blood-stage vaccine. MF Good DC Kaslow LH Miller, Annu Rev Immunol 1998 16 57 87
18. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum. C Uthaipibull B Aufiero SE Syed B Hansen JA Guevara Patĩo E Angov IT Ling K Fegeding WD Morgan C Ockenhouse B Birdsall J Feeney JA Lyon AA Holder, J Mol Biol 2001 307 1381 1394
19. Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1. S Kumar W Collins A Egan A Yadava O Garraud MJ Blackman JA Guevara Patino C Diggs DC Kaslow, Infect Immun 2000 68 2215 2223
20. Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1). M Nair MG Hinds AM Coley AN Hodder M Foley RF Anders RS Norton, J Mol Biol 2002 322 741 753
21. Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro. W Pan D Huang Q Zhang L Qu D Zhang X Zhang X Xue F Qian, J Immunol 2004 172 6167 6174
22. Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults. J Hu Z Chen J Gu M Wan Q Shen MP Kieny J He Z Li Q Zhang ZH Reed Y Zhu W Li Y Cao L Qu Z Cao Q Wang H Liu X Pan X Huang D Zhang X Xue W Pan, PLoS One 2008 3 e1952
23. A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria. E Malkin J Hu Z Li Z Chen X Bi Z Reed F Dubovsky J Liu Q Wang X Pan T Chen B Giersing Y Xu X Kang J Gu Q Shen K Tucker E Tierney W Pan C Long Z Cao, Vaccine 2008 26 6864 6873
24. Heteronuclear multidimensional NMR experiments for the structure determination of proteins in solutions employing pulsed field gradients. M Sattler J Schleucher C Griesinger, Prog Nucl Mag Res Sp 1999 34 93 158
25. JNMRPipe: a multidimensional spectral processing system based on UNIX pipes. F Delaglio S Grzesiek GW Vuister G Zhu J Pfeifer A Bax, Biomol NMR 1995 6 277 293
26. Using NMRView to visualize and analyze the NMR spectra of macromolecules. BA Johnson, Methods Mol Biol 2004 278 313 52
27. 15N NMR relaxation. NA Farrow R Muhandiram AU Singer SM Pascal CM Kay G Gish SE Shoelson T Pawson JD Forman-Kay LE Kay, Biochemistry 1994 33 5984 6003
28. 15N relaxation with monomer/dimer equilibration. D Fushman S Cahill D Cowburn, J Mol Biol 1997 266 173 194
29. 15N resonances of domain III of the ectodomain of apical membrane antigen 1 from Plasmodium falciparum. M Nair AN Hodder MG Hinds RF Anders RS Norton, J Biomol NMR 2001 19 85 86
30. Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1. WD Morgan B Birdsall TA Frenkiel MG Gradwell PA Burghaus SE Syed C Uthaipibull AA Holder J Feeney, J Mol Biol 1999 289 113 122
31. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. JA Chappel AA Holder, Mol Biochem Parasitol 1993 60 303 311
32. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. MJ Blackman TJ Scott-Finnigan S Shai AA Holder, J Exp Med 1994 180 389 393
33. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. JA Guevara Patĩo AA Holder JS McBride MJ Blackman, J Exp Med 1997 186 1689 1699